Polatuzumab Vedotin in PreviouslyUntreated Diffuse Large B-Cell Lymphoma. International Academy for Clinical Hematology IACH 43:40 2 years ago 953 Далее Скачать
Dr. Pagel on the Implications of Polatuzumab Vedotin Approval in DLBCL OncLive 1:35 4 years ago 168 Далее Скачать
Updated results of glofitamab plus polatuzumab vedotin combination therapy in DLBCL, including HGBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:54 11 months ago 351 Далее Скачать
Advancements in the DLBCL treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 0:46 3 years ago 244 Далее Скачать
Brain tumor organoids accurately model patient response to CAR T cell therapy LetsTalkMedicine 0:45 2 days ago 491 Далее Скачать
Polatuzumab Vedotin in PreviouslyUntreated Diffuse Large B-Cell Lymphoma International Academy for Clinical Hematology IACH 43:40 2 years ago 145 Далее Скачать
How the treatment of DLBCL and FL are changing in the UK VJHemOnc – Video Journal of Hematology & HemOnc 3:01 2 years ago 806 Далее Скачать
Relapsed and Refractory Diffuse Large B-Cell Lymphoma Lymphoma Research Foundation 46:48 1 year ago 6 890 Далее Скачать
Treatment options for patients with DLBCL who relapse after CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:14 1 year ago 642 Далее Скачать
A breakthrough therapy: polatuzumab vedotin plus BR for R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 4:59 6 years ago 2 301 Далее Скачать
Polatuzumab vedotin combined with R-ICE as second-line therapy in R/R diffuse large B-cell lymphoma ecancer 1:59 1 year ago 121 Далее Скачать
[lymphoma] After Polatuzumab and CAR-T appeared, Lymphoma Treatment Cost Concerns David Lauren Research | Oncology in 3 minutes. 4:56 2 years ago 47 Далее Скачать
Polatuzumab vedotin in patients with LBCL who have relapsed after CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 3:47 2 years ago 369 Далее Скачать
CAR T-Cell Therapy for Patients with Relapsed Diffuse Large B-Cell Lymphoma GRACE - Global Resource for Advancing Cancer Education 5:04 1 year ago 147 Далее Скачать
How the 5-year data of POLARIX contribute to understanding long-term efficacy of Pola-R-CHP in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:07 2 weeks ago 44 Далее Скачать
How will front-line use of polatuzumab vedotin influence patient outcomes in DLBCL? Lymphoma Hub 3:25 5 years ago 341 Далее Скачать
Exploring Potential Curative Therapies for Diffuse Large B-Cell Lymphoma Targeted Oncology 1:32 4 years ago 349 Далее Скачать
Updates on tafasitamab for the treatment of DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:05 2 years ago 378 Далее Скачать
Polatuzumab vedotin combined with chemotherapy in untreated large B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:15 10 months ago 248 Далее Скачать
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo OncBrothers: Practice-Changing Cancer Discussions 24:57 4 months ago 1 915 Далее Скачать
Catherine Diefenbach: Polatuzumab Vedotin for Follicular Lymphoma American Society of Hematology 4:56 5 years ago 873 Далее Скачать
ADC polatuzumab vedotin in combinations for relapsed lymphoma ecancer 4:31 6 years ago 167 Далее Скачать
POLARIX study: frontline therapy in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:44 2 years ago 912 Далее Скачать
POLARIX Trial and Polatuzumab in Frontline Chemotherapy for DLBCL - 2024 Blood Cancer OncTalk GRACE - Global Resource for Advancing Cancer Education 5:21 1 month ago 43 Далее Скачать
Why Combine Mosunetuzumab and Polatuzumab Vedotin? Blood Cancers Today 3:10 2 years ago 101 Далее Скачать
The use of ADCs & bispecific antibodies before and after CAR-T therapy in third-line DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 4:10 1 year ago 598 Далее Скачать
Limitations of CAR T-cell therapy for DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:20 3 years ago 486 Далее Скачать
Treatment options for patients with LBCL who relapse or are refractory to initial treatment VJHemOnc – Video Journal of Hematology & HemOnc 3:04 5 months ago 50 Далее Скачать
Current treatment landscape of DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 4:00 4 years ago 463 Далее Скачать
The current and future ADC treatment landscape for lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 9:09 3 years ago 112 Далее Скачать
Two Doses of Polatuzumab Vedotin in Patients With Relapsed/Refractory Follicular Lymphoma Targeted Oncology 2:25 9 years ago 361 Далее Скачать
Glofitamab and polatuzumab vedotin in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 5:46 2 years ago 718 Далее Скачать
What does the first-line data for polatuzumab vedotin tell us about its role in R/R DLBCL? Lymphoma Hub 5:11 2 years ago 295 Далее Скачать
Novel targets and agents for lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 7:45 6 years ago 226 Далее Скачать
Safety and Efficacy of Mosunetuzumab Plus Polatuzumab Vedotin Blood Cancers Today 2:54 2 years ago 26 Далее Скачать
The influence of bridging therapy on outcomes in large B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 4:00 2 years ago 66 Далее Скачать
Managing relapse post-CAR-T therapy in DLBCL & the need to change clinical trial inclusion criteria VJHemOnc – Video Journal of Hematology & HemOnc 3:55 2 years ago 197 Далее Скачать
Trial updates in NHL: RELEVANCE, polatuzumab, TRANSCEND-NHL-001 & Hu5F9-G4 VJHemOnc – Video Journal of Hematology & HemOnc 2:03 6 years ago 162 Далее Скачать
POLARIX: Polatuzumab vedotin and R-CHP superior to R-CHOP in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 3:12 3 years ago 1 954 Далее Скачать
Combination of mosunetuzumab with CHOP in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:13 3 years ago 69 Далее Скачать
Updates in the DLBCL treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 1:49 3 years ago 150 Далее Скачать
Exciting combinations under investigation in lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:14 3 years ago 118 Далее Скачать
Expert Discusses Challenges of Using CAR T-Cell Therapy to Treat Diffuse Large B-Cell Lymphoma OncLive 0:53 5 years ago 131 Далее Скачать
SUNMO trial design: mosunetuzumab plus polatuzumab vedotin vs R-GemOx in R/R NHL VJHemOnc – Video Journal of Hematology & HemOnc 0:56 2 years ago 221 Далее Скачать
Efficacy and safety of M-Pola for R/R B-cell NHL VJHemOnc – Video Journal of Hematology & HemOnc 5:04 3 years ago 48 Далее Скачать
CAR T-Cell Therapy Patients with Relapsed Diffuse Large B-Cell Lymphoma - Blood Cancer Video Library GRACE - Global Resource for Advancing Cancer Education 4:44 2 years ago 361 Далее Скачать
Contemporary approaches to the management of R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:19 2 years ago 60 Далее Скачать
Novel agents vs. standard chemotherapy for first-line salvage treatment following CAR-T in LBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:51 1 year ago 160 Далее Скачать
Lymphoma highlights from ASH 2021 VJHemOnc – Video Journal of Hematology & HemOnc 2:57 2 years ago 194 Далее Скачать
Will Newer Therapies Be Curative for Diffuse Large B-Cell Lymphoma Patients? Patient Empowerment Network 2:01 1 year ago 32 Далее Скачать
Dr. Pagel on the Utility of CAR T-Cell Therapy in Relapsed/Refractory DLBCL OncLive 2:17 4 years ago 108 Далее Скачать
CAR T-cell update: what’s new in DLBCL and MM? VJHemOnc – Video Journal of Hematology & HemOnc 2:55 6 years ago 96 Далее Скачать
Dr. Neelapu on Third-Line CAR T-Cell Therapy in Large B-Cell Lymphoma OncLive 1:43 5 years ago 419 Далее Скачать
Bispecific antibodies in NHL: current insights and ongoing studies VJHemOnc – Video Journal of Hematology & HemOnc 3:20 1 year ago 226 Далее Скачать
Outcomes of CAR-T therapy in patients with refractory B-cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:29 3 years ago 121 Далее Скачать
Understanding CAR T-cell Therapy in Lymphoma Lymphoma Australia 12:46 5 years ago 1 330 Далее Скачать
New data on DLBCL in the UK and its impact on treatment decisions VJHemOnc – Video Journal of Hematology & HemOnc 6:33 2 years ago 229 Далее Скачать
CAR T-cell therapy for B-cell lymphomas: a focus on improving CR VJHemOnc – Video Journal of Hematology & HemOnc 3:04 5 years ago 173 Далее Скачать
CAR T-cells in lymphoma: new advances and practical aspects International Academy for Clinical Hematology IACH 54:11 3 years ago 428 Далее Скачать
An Overview of Current DLBCL Treatment Approaches Patient Empowerment Network 5:34 3 years ago 29 Далее Скачать
Current immunotherapeutic approaches in DLBCL: the value of CAR-T cells and bispecific antibodies VJHemOnc – Video Journal of Hematology & HemOnc 2:52 1 year ago 280 Далее Скачать
How the standard of care for DLBCL is changing with the introduction of novel agents VJHemOnc – Video Journal of Hematology & HemOnc 1:28 1 year ago 123 Далее Скачать
CAR T cell Options for Relapsed/Refractory DLBCL Targeted Oncology 0:48 5 years ago 201 Далее Скачать
Dr. Andreadis on the Current State of CAR T-Cell Therapy in Lymphoma OncLive 1:41 6 years ago 93 Далее Скачать
Dose-escalation of mosunetuzumab with polatuzumab vedotin for R/R b-cell non-Hodgkin’s lymphoma ecancer 7:16 3 years ago 163 Далее Скачать
CAR-T therapy for R/R aggressive B-cell NHL VJHemOnc – Video Journal of Hematology & HemOnc 4:05 3 years ago 70 Далее Скачать
Genentech - FDA Approval of Polivy ® Combination for Treatment of Certain Types of Previously Untre HPR 8:21 1 year ago 396 Далее Скачать
The future of CAR T-cell therapy in lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:08 3 years ago 73 Далее Скачать
Immunotherapy Beyond CAR T-Cell Therapy Lymphoma Research Foundation 44:46 1 year ago 309 Далее Скачать
Pola-G-Len for R/R follicular lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:40 5 years ago 104 Далее Скачать
Summary of Two Important Lymphoma Studies - POLARIX andd SWOG S1826 #oncology #cancer #Lymphoma OncBrothers: Practice-Changing Cancer Discussions 0:43 1 year ago 272 Далее Скачать
The need for new treatment strategies for patients with DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 2 years ago 189 Далее Скачать
Promising Results for Bendamustine/Rituximab Plus Polatuzumab Vedotin in Lymphomas Targeted Oncology 0:56 6 years ago 445 Далее Скачать
What's New in the Approach to DLBCL Upfront and in the Relapsed Setting Beyond CAR T HMP Education 21:56 4 years ago 1 143 Далее Скачать
The need for more effective, less toxic therapies in frontline DLBCL treatment VJHemOnc – Video Journal of Hematology & HemOnc 2:18 1 year ago 234 Далее Скачать
Liso-cel (Breyanzi) Shows Curative Potential in R/R DLBCL | Manali Kamdar, MD | EHA 2024 HealthTree Foundation for Blood Cancers 6:43 6 months ago 68 Далее Скачать
Looking forward to ASH 2021: key updates in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 3:48 3 years ago 558 Далее Скачать
Debate: Will CAR-T cell therapies have a major impact in recurrent DLBCL over the next 3 years - No HMP Education 16:47 6 years ago 270 Далее Скачать
Can CAR-T cells replace ASCT in DLBCL? VJHemOnc – Video Journal of Hematology & HemOnc 3:05 5 years ago 217 Далее Скачать
Understanding CAR T cell therapy for the treatment of Lymphoma Lymphoma Australia 57:44 5 years ago 467 Далее Скачать
